Volume | 1,018,261 |
|
|||||
Noticias | - | ||||||
Máximo del Dia | 4.17 | Mínimo Máximo |
|||||
Minimo del Dia | 3.67 |
Nombre de la Acción | Símbolo de la Acción | Bolsa de Valores | Tipo de Valor |
---|---|---|---|
ADC Therapeutics SA | ADCT | NYSE | Acción Común |
Precio de Apertura | Precio Mínimo | Precio Máximo | Precio de cierre | Precio Anterior |
---|---|---|---|---|
4.10 | 3.67 | 4.17 | 3.73 | 4.11 |
Operaciones | Volume Operado de la Acción | Precio Promedio Ponderado | Volume Financiero | Volumen promedio | Rango 52 semanas |
---|---|---|---|---|---|
7,552 | 1,018,261 | US$ 3.81 | US$ 3,883,375 | - | 0.359908 - 6.04 |
Último Operado | Tipo de Operación | Cantidad Operada | Precio Operado | Divisa |
---|---|---|---|---|
18:22:50 | 61 | US$ 3.74 | USD |
Información Financiera ADC Therapeutics SA ADCT
Capitalización de Mercado [m] | Acciones en circulación | Float | Ingresos | Ganancia/Pérdida | Utilidad por Acción (UPA) | Ratio Precio/Utilidad |
---|---|---|---|---|---|---|
308.66M | 82.53M | - | 69.56M | -234.53M | -2.84 | - |
Interés de corto | Dividendos Por Acción | Rendimiento del Dividendo | Fecha esperada de dividendos | Transacciones ejecutivas | % de acciones controladas por todos los ejecutivos y 5% propietarios: |
---|---|---|---|---|---|
- | - | - | - |
Noticias sobre ADC Therapeutics SA ADCT
Fecha | Hora | Fuente | Noticias Artículo |
---|---|---|---|
15/5/2024 | 06:15 | GlobeNewswire Inc. | ADC Therapeutics to Participate in the H.C. Wainwright 2nd.. |
14/5/2024 | 11:32 | Edgar (US Regulatory) | Form 8-K - Current report |
09/5/2024 | 15:06 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
09/5/2024 | 06:15 | GlobeNewswire Inc. | ADC Therapeutics to Participate in 2024 RBC Capital Markets.. |
08/5/2024 | 15:07 | Edgar (US Regulatory) | Form 8-K - Current report |
07/5/2024 | 15:06 | Edgar (US Regulatory) | Form 144 - Report of proposed sale of securities |
07/5/2024 | 15:02 | Edgar (US Regulatory) | Form 424B5 - Prospectus [Rule 424(b)(5)] |
06/5/2024 | 06:30 | GlobeNewswire Inc. | ADC Therapeutics Announces $105 Million Underwritten.. |
06/5/2024 | 05:51 | Edgar (US Regulatory) | Form 424B5 - Prospectus [Rule 424(b)(5)] |
06/5/2024 | 05:38 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
06/5/2024 | 05:29 | Edgar (US Regulatory) | Form 8-K - Current report |
06/5/2024 | 05:10 | GlobeNewswire Inc. | ADC Therapeutics Reports First Quarter 2024 Financial.. |
Histórico de Datos ADCT
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 4.23 | 4.32 | 3.67 | 4.09 | 467,772 | -0.42 | -9.93% |
1 Month | 4.72 | 5.17 | 3.67 | 4.44 | 578,937 | -0.91 | -19.28% |
3 Months | 5.32 | 5.38 | 3.23 | 4.53 | 559,815 | -1.51 | -28.38% |
6 Months | 0.70 | 6.04 | 0.684 | 3.27 | 745,462 | 3.11 | 444.29% |
1 Year | 2.58 | 6.04 | 0.359908 | 2.63 | 563,402 | 1.23 | 47.67% |
3 Years | 21.00 | 32.00 | 0.359908 | 6.18 | 429,462 | -17.19 | -81.86% |
5 Years | 30.00 | 56.5899 | 0.359908 | 10.72 | 387,508 | -26.19 | -87.30% |